Pharmaceuticals

Health
5:00 am
Fri February 18, 2011

Drug Maker Working on Smallpox Treatment

The federal government has awarded drug maker Chimerix a nearly $25 million grant to develop an anti-viral drug for smallpox.

The Durham-based company’s lead candidate is a drug called CMX001. Chimerix President and CEO Kenneth Moch says the government wants the treatment ready in case of a smallpox outbreak as the result of a bioterrorist attack.
 

Read more

Pages